676 related articles for article (PubMed ID: 19056013)
1. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
2. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Lam SW; Bauer SR; Cha SS; Oyen LJ
Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
[TBL] [Abstract][Full Text] [Related]
3. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
4. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
5. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
6. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.
Rady MY; Johnson DJ; Patel B; Larson J; Helmers R
Arch Surg; 2005 Jul; 140(7):661-8; discussion 669. PubMed ID: 16027331
[TBL] [Abstract][Full Text] [Related]
7. Comparing hydrocortisone and methylprednisolone in patients with septic shock.
Yu TJ; Liu YC; Yu CC; Tseng JC; Hua CC; Wu HP
Adv Ther; 2009 Jul; 26(7):728-35. PubMed ID: 19629409
[TBL] [Abstract][Full Text] [Related]
8. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
9. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive drugs for vasodilatory shock in ICU.
Holmes CL; Walley KR
Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ
J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
[TBL] [Abstract][Full Text] [Related]
12. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
13. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
14. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
Raurich JM; Llompart-Pou JA; Ibáñez J; Frontera G; Pérez O; García L; Ayestarán JI
J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
[TBL] [Abstract][Full Text] [Related]
15. Before-after study of a standardized hospital order set for the management of septic shock.
Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
[TBL] [Abstract][Full Text] [Related]
16. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
de Jong MF; Beishuizen A; Spijkstra JJ; Groeneveld AB
Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
[TBL] [Abstract][Full Text] [Related]
17. Adrenal exhaustion in septic patients with vasopressor dependency.
Guzman JA; Guzman CB
J Crit Care; 2007 Dec; 22(4):319-23. PubMed ID: 18086403
[TBL] [Abstract][Full Text] [Related]
18. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
19. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
20. Dear vasopressin, where is your place in septic shock?
Duenser MW; Hasibeder WR
Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
